Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

Table 1 Demographic and clinical characteristics in patients with NVAF n = 593

Variables	Classification	N (%)
Gender	Female	281 (47.4)
Payment	Self-paying	130 (21.9)
Age, years	< 60	76 (12.8)
	60~69	157 (26.5)
	70~79	205 (34.6)
	≥80	155 (26.1)
Education	Primary school or below	316 (53.3)
	Junior high school	145 (24.5)
	Senior high school and above	132 (22.2)
AF type	Paroxysmal	381 (64.3)
	Persistent	172 (29.0)
	Permanent	40 (6.7)
Duration, years	< 5	335 (56.3)
Severity of symptom	Asymptomatic	61 (10.3)
	Mild	334 (56.3)
	Moderate	169 (28.5)
	Severe	29 (4.9)
Stroke	Yes	66 (11.1)
Concomitant disease
Hypertension	Yes	359 (60.5)
Diabetes mellitus	Yes	118 (19.9)
Coronary heart disease	Yes	138 (23.2)
Heart failure	Yes	94 (15.8)
Vascular disease	Yes	27 (4.6)
Hyperlipidemia	Yes	38 (6.4)
Impaired renal/liver function	Yes	29 (4.9)
HAS-BLED, score	< 3	531 (89.5)
CHA₂DS₂-VAS_C, score	Male: 0~2; female: 0~1	161 (27.2)
	Male ≥3; female ≥2	432 (72.8)

Abbreviations: AF Atrial fibrillation, CHA₂DS₂-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years,sex category (female), HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, NVAF Non-valvular atrial fibrillation, TIA Transient ischemic attack

ISSN: 1471-2261